Intravenous Mepolizumab In Children With Eosinophilic Esophagitis
Status:
Completed
Trial end date:
2008-11-25
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of
intravenous mepolizumab in pediatric subjects with eosinophilic esophagitis.